Disclosures: Loghman Salimzadeh: Nothing to Disclose, Stuti Shah: Nothing to Disclose, Danie La: Nothing to Disclose, Hilario Ramos: Bluejay Therapeutics: Employee, Bluejay Therapeutics: Stock privately held company, Nancy Shulman: Bluejay Therapeutics, INC: Salary and equity, Hassan Javanbakht: Nothing to Disclose, Adam Gehring: Nothing to Disclose 452 PRECLINICAL PHARMACOKINETICS OF EDP-514, AN ORAL, ONCE-DAILY ANTIVIRAL TREATMENT FOR HEPATITIS B VIRUS Meng Huang 1 Khanh Hoang 1 Jonathan Kibel 1 Shucha Zhang 1 Lisha Xu 1 Yang Li 1 Indy Zang 1 Daniel Leonard 1 Siu-Lung Chan 1 Joshua Klaene 1 Yat Sun Or 1 Li-Juan Jiang 1 , 1 Enanta Pharmaceuticals Background: Hepatitis B virus (HBV) is a global public health threat that causes approximately 1.5 million new infections every year
6) Utility of gene testing kits for preoperative diagnosis of follicular tumors The preoperative diagnosis of follicular tumors has presented a longstanding challenge
RNA isolation and analysis The leaf samples were frozen in liquid nitrogen and ground in a mortar, followed by RNA extraction using the innuPREP Plant RNA Kit (Analytik Jena, Jena, Germany) according to the kit instructions
Reactive oxygen radicals in signaling and damage in the ischemic brain
22 Clinical trials in patients with other types of inflammatory skin disorders suggest GLA-rich oil supplementation may have positive effects on skin health, improving skin barrier function and skin hydration and reducing symptoms in those with atopic dermatitis and acne
